ID

28842

Descripción

Study ID: 100723 Clinical Study ID: AXR100723 Study Title: A 24 Week Randomized, Double-blind, Double-dummy, Multicenter Study to Compare the Efficacy of Formulation X and AVANDIA™ (8mg OD) in Subjects with Type 2 Diabetes Mellitus Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: rosiglitazone Trade Name: Avandia; Avandia XR; Avandia XR,Rosiglitazone XR,Avandia; Rosiglitazone XR Study Indication: Diabetes Mellitus, Type 2 Documentation part: Pre-Screening - Visit 1

Palabras clave

Versiones (1)
  1. 8/2/18 8/2/18 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

8 de febrero de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Efficacy of Formulation X and AVANDIA in Subjects with Type 2 Diabetes Mellitus 100723

Inglés

Pre-Screening - Visit 1

1 formularios  
Subject Eligibility for Continuation
Descripción

Subject Eligibility for Continuation

Alias
UMLS CUI-1
C2348568
UMLS CUI-2
C0805733
UMLS CUI-3
C0013893
Center
Descripción

Center

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Subject ID
Descripción

Subject ID

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Initials
Descripción

Initials

Tipo de datos

text

Alias
UMLS CUI [1]
C2986440
Visit Date
Descripción

Visit Date

Tipo de datos

date

Alias
UMLS CUI [1]
C1320303
I f known, record local lab HbA1c value drawn within 6 weeks prior to Pre-Screening visit
Descripción

HbA1c

Tipo de datos

float

Unidades de medida
  • %
Alias
UMLS CUI [1]
C0019018
%
Based upon their prior diabetes therapy does the subject meet one of the following HbA1c criteria? - Drug Naïve and HbA1c > = 7.5 and < = 11% - Oral antidiabetic monotherapy and HbA1c > = 7 and < = 10% - Oral antidiabetic combinationtherapy and HbA1c > = 6.5 and < = 10%
Descripción

HbA1c Criteria

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019018
UMLS CUI [1,2]
C1516637
I f 'No', select the criteria that was not met.
Descripción

HbA1c criteria that was not met

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0019018
UMLS CUI [1,2]
C1516637
Were lab samples obtained?
Descripción

lab samples

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005834
UMLS CUI [2]
C0005834
Date Sample Taken
Descripción

Date Sample Taken

Tipo de datos

date

Alias
UMLS CUI [1]
C1302413
Volver a la parte superior de la página

Similar models

Pre-Screening - Visit 1

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Subject Eligibility for Continuation
C2348568 (UMLS CUI-1)
C0805733 (UMLS CUI-2)
C0013893 (UMLS CUI-3)
Center
Item
Center
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Initials
Item
Initials
text
C2986440 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
HbA1c
Item
I f known, record local lab HbA1c value drawn within 6 weeks prior to Pre-Screening visit
float
C0019018 (UMLS CUI [1])
HbA1c Criteria
Item
Based upon their prior diabetes therapy does the subject meet one of the following HbA1c criteria? - Drug Naïve and HbA1c > = 7.5 and < = 11% - Oral antidiabetic monotherapy and HbA1c > = 7 and < = 10% - Oral antidiabetic combinationtherapy and HbA1c > = 6.5 and < = 10%
boolean
C0019018 (UMLS CUI [1,1])
C1516637 (UMLS CUI [1,2])
Item
I f 'No', select the criteria that was not met.
integer
C0019018 (UMLS CUI [1,1])
C1516637 (UMLS CUI [1,2])
HbA1c criteria that was not met
Code List
I f 'No', select the criteria that was not met.
CL Item
Drug Naïve and HbA1c > = 7.5 and < = 11% (1)
CL Item
Oral antidiabetic monotherapy and HbA1c > = 7 and < = 10%  (2)
CL Item
Oral antidiabetic combinationtherapy and HbA1c > = 6.5 and < = 10% (3)
lab samples
Item
Were lab samples obtained?
boolean
C0005834 (UMLS CUI [1])
C0005834 (UMLS CUI [2])
Date Sample Taken
Item
Date Sample Taken
date
C1302413 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial